Neurobiological Aspects of Sleep Physiology

Neurologic Clinics

Volumn 30, Issue 4, 2012, Pages 963-985

  Moszczynski, Alex ^a   Murray, Brian James ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Alertness; Sleep; Sleep disorders; Sleep physiology; Wakefulness

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACETYLCHOLINE; ADENOSINE; ADENOSINE A2A RECEPTOR; ALCOHOL; AMPHETAMINE DERIVATIVE; ANESTHETIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ATROPINE; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CLONAZEPAM; COCAINE; DOPAMINE; HISTAMINE; HYPNOTIC AGENT; MODAFINIL; NEOSTIGMINE; NORADRENALIN; OREXIN; RESERPINE; SEDATIVE AGENT; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOLPIDEM;

ALERTNESS; AROUSAL; BRAIN CORTEX; BRAIN REGION; CHOLINERGIC SYSTEM; CIRCADIAN RHYTHM; DREAMING; DRUG EFFECT; ELECTROENCEPHALOGRAM; GENETIC TRANSCRIPTION; HUMAN; MONOAMINERGIC SYSTEM; MUSCLE ATONIA; NARCOLEPSY; NERVE PROJECTION; NEUROANATOMY; NEUROBIOLOGY; NEUROLOGIC DISEASE; NONHUMAN; NONREM SLEEP; PARASOMNIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; REVIEW; SEDATION; SIDE EFFECT; SLEEP; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP PATTERN; SLEEP WAKING CYCLE; SLEEP WALKING; SOMNOLENCE; THALAMOCORTICAL TRACT; WAKEFULNESS;

ANIMALS; BRAIN; CIRCADIAN CLOCKS; HUMANS; NEURONS; SLEEP; SLEEP DISORDERS; WAKEFULNESS;

EID: 84867903405     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2012.08.001     Document Type: Review

References (127)

1. Staub F., Bogousslavsky J. Fatigue after stroke: a major but neglected issue. Cerebrovasc Dis 2001, 12:75-81.
2. Cantor F. Central and peripheral fatigue: exemplified by multiple sclerosis and myasthenia gravis. PM R 2010, 2:399-405.
3. Rotstein D., O'Connor P., Lee L., et al. Multiple sclerosis fatigue is associated with reduced psychomotor vigilance. Can J Neurol Sci 2012, 39:180-184.
4. McElhiney M.C., Rabkin J.G., Gordon P.H., et al. Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry 2009, 80:1146-1149.
5. Gerber P.D., Barrett J.E., Barrett J.A., et al. The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med 1992, 7:170-173.
6. Thannickal T.C., Lai Y.Y., Siegel J.M. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 2007, 130:1586-1595.
7. Knie B., Mitra M.T., Logishetty K., et al. Excessive daytime sleepiness in patients with Parkinson's disease. CNS Drugs 2011, 25:203-212.
8. Drouot X., Moutereau S., Lefaucheur J.P., et al. Low level of ventricular CSF orexin-A is not associated with objective sleepiness in PD. Sleep Medicine 2011, 12:936-937.
9. American Academy of Sleep Medicine The international classification of sleep disorders: diagnostic and coding manual 2005, American Academy of Sleep Medicine, Westchester (IL). 2nd edition.
10. Lurie A. Obstructive sleep apnea in adults: epidemiology, clinical presentation, and treatment options. Adv Cardiol 2011, 46:1-42.
11. Winkelman J.W., Shahar E., Sharief I., et al. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008, 70:35-42.
12. Doi Y., Minowa M., Tango T. Impact and correlates of poor sleep quality in Japanese white-collar employees. Sleep 2003, 26:467-471.
13. Martin J.L., Fiorentino L., Jouldjian S., et al. Sleep quality in residents of assisted living facilities: effect on quality of life, functional status, and depression. J Am Geriatr Soc 2010, 58:829-836.
14. Sharma S.K., Agrawal S., Damodaran D., et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011, 365:2277-2286.
15. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
16. Marin J.M., Carrizo S.J., Vicente E., et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
17. Chan W., Coutts S.B., Hanly P. Sleep apnea in patients with transient ischemic attack and minor stroke: opportunity for risk reduction of recurrent stroke?. Stroke 2010, 41:2973-2975.
18. Ryan C.M., Bayley M., Green R., et al. Influence of continuous positive airway pressure on outcomes of rehabilitation in stroke patients with obstructive sleep apnea. Stroke 2011, 42:1062-1067.
19. Perrin C., D'Ambrosio C., White A., et al. Sleep in restrictive and neuromuscular respiratory disorders. Semin Respir Crit Care Med 2005, 26:117-130.
20. Malow B.A., Foldvary-Schaefer N., Vaughn B.V., et al. Treating obstructive sleep apnea in adults with epilepsy: a randomized pilot trial. Neurology 2008, 71:572-577.
21. Iber C., American Academy of Sleep Medicine The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specifications 2007, American Academy of Sleep Medicine, Westchester (IL).
22. Schenck C.H., Mahowald M.W. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002, 25:120-138.
23. Postuma R.B., Gagnon J.F., Vendette M., et al. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009, 72:1296-1300.
24. Kupfer D.J., Foster F.G. Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression. Lancet 1972, 2:684-686.
25. Chemelli R.M., Willie J.T., Sinton C.M., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
26. Lin L., Faraco J., Li R., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
27. Siegel J.M. Do all animals sleep?. Trends Neurosci 2008, 31:208-213.
28. Everson C.A., Bergmann B.M., Rechtschaffen A. Sleep deprivation in the rat: III. Total sleep deprivation. Sleep 1989, 12:13-21.
29. Borbely A.A., Achermann P. Sleep homeostasis and models of sleep regulation. J Biol Rhythms 1999, 14:557-568.
30. Dijk D.J., Czeisler C.A. Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci 1995, 15:3526-3538.
31. Borbely A.A., Baumann F., Brandeis D., et al. Sleep deprivation: effect on sleep stages and EEG power density in man. Electroencephalogr Clin Neurophysiol 1981, 51:483-495.
32. Medori R., Tritschler H.J., LeBlanc A., et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 1992, 326:444-449.
33. Kang J.E., Lim M.M., Bateman R.J., et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009, 326:1005-1007.
34. Tononi G., Cirelli C. Sleep function and synaptic homeostasis. Sleep Med Rev 2006, 10:49-62.
35. Manthena P., Zee P.C. Neurobiology of circadian rhythm sleep disorders. Curr Neurol Neurosci Rep 2006, 6:163-168.
36. Czeisler C.A., Duffy J.F., Shanahan T.L., et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999, 284:2177-2181.
37. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418:935-941.
38. Dijk D.J., Beersma D.G., Daan S. EEG power density during nap sleep: reflection of an hourglass measuring the duration of prior wakefulness. J Biol Rhythms 1987, 2:207-219.
39. Triarhou L.C. The percipient observations of Constantin von Economo on encephalitis lethargica and sleep disruption and their lasting impact on contemporary sleep research. Brain Res Bull 2006, 69:244-258.
40. Sallanon M., Sakai K., Buda C., et al. Increase of paradoxical sleep induced by microinjections of ibotenic acid into the ventrolateral part of the posterior hypothalamus in the cat. Arch Ital Biol 1988, 126:87-97.
41. Steriade M. The corticothalamic system in sleep. Front Biosci 2003, 8:d878-d899.
42. Langford G.W., Meddis R., Pearson A.J. Awakening latency from sleep for meaningful and non-meaningful stimuli. Psychophysiology 1974, 11:1-5.
43. Amzica F., Steriade M. The K-complex: its slow (<1-Hz) rhythmicity and relation to delta waves. Neurology 1997, 49:952-959.
44. Jahnke K., von Wegner F., Morzelewski A., et al. To wake or not to wake? The two-sided nature of the human K-complex. Neuroimage 2012, 59:1631-1638.
45. Caporro M., Haneef Z., Yeh H.J., et al. Functional MRI of sleep spindles and K-complexes. Clin Neurophysiol 2012, 123:303-309.
46. Steriade M., Timofeev I., Grenier F. Natural waking and sleep states: a view from inside neocortical neurons. J Neurophysiol 2001, 85:1969-1985.
47. Massimini M., Huber R., Ferrarelli F., et al. The sleep slow oscillation as a traveling wave. J Neurosci 2004, 24:6862-6870.
48. Vaughn B.V., D'Cruz O.F. Sleep and epilepsy. Clinical sleep disorders 2005, 403-419. Ovid Technologies, Lippincott Williams & Wilkins, Philadelphia. P.R. Carney, R.B. Berry, J.D. Geyer (Eds.).
49. Rechtschaffen A., Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages in human subjects 1968, US Government Printing Office, Los Angeles.
50. Moruzzi G., Magoun H.W. Brain stem reticular formation and activation of the EEG. Electroencephalogr Clin Neurophysiol 1949, 1:455-473.
51. Steriade M., Oakson G., Ropert N. Firing rates and patterns of midbrain reticular neurons during steady and transitional states of the sleep-waking cycle. Exp Brain Res 1982, 46:37-51.
52. Stewart D.J., MacFabe D.F., Vanderwolf C.H. Cholinergic activation of the electrocorticogram: role of the substantia innominata and effects of atropine and quinuclidinyl benzilate. Brain Res 1984, 322:219-232.
53. Jasper H.H., Tessier J. Acetylcholine liberation from cerebral cortex during paradoxical (REM) sleep. Science 1971, 172:601-602.
54. Montplaisir J.Y. Cholinergic mechanisms involved in cortical activation during arousal. Electroencephalogr Clin Neurophysiol 1975, 38:263-272.
55. Schott B., Michel D., Mouret J., et al. Rev Neurol (Paris) 1972, 127:157-171. [in French].
56. Hobson J.A., McCarley R.W., Wyzinski P.W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 1975, 189:55-58.
57. McCormick D.A., Bal T. Sleep and arousal: thalamocortical mechanisms. Annu Rev Neurosci 1997, 20:185-215.
58. Jones B.E. Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems. Ann N Y Acad Sci 2008, 1129:26-34.
59. Carter M.E., Yizhar O., Chikahisa S., et al. Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat Neurosci 2010, 13:1526-1533.
60. Wu M.F., Gulyani S.A., Yau E., et al. Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience 1999, 91:1389-1399.
61. Wu M.F., John J., Boehmer L.N., et al. Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs. J Physiol 2004, 554:202-215.
62. Cui L., Wang J.H., Wang M., et al. Injection of L: -glutamate into the insular cortex produces sleep apnea and serotonin reduction in rats. Sleep Breath 2011, [Epub ahead of print].
63. Portas C.M., Thakkar M., Rainnie D., et al. Microdialysis perfusion of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the dorsal raphe nucleus decreases serotonin release and increases rapid eye movement sleep in the freely moving cat. J Neurosci 1996, 16:2820-2828.
64. Steininger T.L., Alam M.N., Gong H., et al. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res 1999, 840:138-147.
65. Monnier M., Sauer R., Hatt A.M. The activating effect of histamine on the central nervous system. Int Rev Neurobiol 1970, 12:265-305.
66. Vanni-Mercier G., Sakai K., Jouvet M. C R Acad Sci III 1984, 298:195-200. [in French].
67. Leger L., Sapin E., Goutagny R., et al. Dopaminergic neurons expressing Fos during waking and paradoxical sleep in the rat. J Chem Neuroanat 2010, 39:262-271.
68. Wisor J.P., Eriksson K.S. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 2005, 132:1027-1034.
69. Peyron C., Tighe D.K., van den Pol A.N., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
70. Takahashi K., Koyama Y., Kayama Y., et al. Effects of orexin on the laterodorsal tegmental neurones. Psychiatry Clin Neurosci 2002, 56:335-336.
71. Mileykovskiy B.Y., Kiyashchenko L.I., Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005, 46:787-798.
72. Lee M.G., Hassani O.K., Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 2005, 25:6716-6720.
73. Thannickal T.C., Moore R.Y., Nienhuis R., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27:469-474.
74. Tsunematsu T., Kilduff T.S., Boyden E.S., et al. Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. J Neurosci 2011, 31:10529-10539.
75. Sherin J.E., Shiromani P.J., McCarley R.W., et al. Activation of ventrolateral preoptic neurons during sleep. Science 1996, 271:216-219.
76. Lu J., Greco M.A., Shiromani P., et al. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci 2000, 20:3830-3842.
77. Szymusiak R., Alam N., Steininger T.L., et al. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res 1998, 803:178-188.
78. Sherin J.E., Elmquist J.K., Torrealba F., et al. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 1998, 18:4705-4721.
79. Steininger T.L., Gong H., McGinty D., et al. Subregional organization of preoptic area/anterior hypothalamic projections to arousal-related monoaminergic cell groups. J Comp Neurol 2001, 429:638-653.
80. Benedetto L., Chase M.H., Torterolo P. GABAergic processes within the median preoptic nucleus promote NREM sleep. Behav Brain Res 2012, 232:60-65.
81. Porkka-Heiskanen T., Strecker R.E., Thakkar M., et al. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 1997, 276:1265-1268.
82. Portas C.M., Thakkar M., Rainnie D.G., et al. Role of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat. Neuroscience 1997, 79:225-235.
83. Krueger J.M. The role of cytokines in sleep regulation. Curr Pharm Des 2008, 14:3408-3416.
84. Saper C.B., Fuller P.M., Pedersen N.P., et al. Sleep state switching. Neuron 2010, 68:1023-1042.
85. Chou T.C., Bjorkum A.A., Gaus S.E., et al. Afferents to the ventrolateral preoptic nucleus. J Neurosci 2002, 22:977-990.
86. Gallopin T., Fort P., Eggermann E., et al. Identification of sleep-promoting neurons in vitro. Nature 2000, 404:992-995.
87. Mochizuki T., Crocker A., McCormack S., et al. Behavioral state instability in orexin knock-out mice. J Neurosci 2004, 24:6291-6300.
88. Sack R.L., Brandes R.W., Kendall A.R., et al. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 2000, 343:1070-1077.
89. Toh K.L., Jones C.R., He Y., et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001, 291:1040-1043.
90. Lu J., Zhang Y.H., Chou T.C., et al. Contrasting effects of ibotenate lesions of the paraventricular nucleus and subparaventricular zone on sleep-wake cycle and temperature regulation. J Neurosci 2001, 21:4864-4874.
91. Chou T.C., Scammell T.E., Gooley J.J., et al. Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J Neurosci 2003, 23:10691-10702.
92. Herzog A.G. Neuroactive properties of reproductive steroids. Headache 2007, 47(Suppl 2):S68-S78.
93. Mong J.A., Baker F.C., Mahoney M.M., et al. Sleep, rhythms, and the endocrine brain: influence of sex and gonadal hormones. J Neurosci 2011, 31:16107-16116.
94. Pringsheim T. Cluster headache: evidence for a disorder of circadian rhythm and hypothalamic function. Can J Neurol Sci 2002, 29:33-40.
95. Hofman M.A., Swaab D.F. Seasonal changes in the suprachiasmatic nucleus of man. Neurosci Lett 1992, 139:257-260.
96. Shouse M.N., Siegel J.M. Pontine regulation of REM sleep components in cats: integrity of the pedunculopontine tegmentum (PPT) is important for phasic events but unnecessary for atonia during REM sleep. Brain Res 1992, 571:50-63.
97. Steriade M., Pare D., Datta S., et al. Different cellular types in mesopontine cholinergic nuclei related to ponto-geniculo-occipital waves. J Neurosci 1990, 10:2560-2579.
98. Lim A.S., Moro E., Lozano A.M., et al. Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons. Ann Neurol 2009, 66:110-114.
99. Lu J., Sherman D., Devor M., et al. A putative flip-flop switch for control of REM sleep. Nature 2006, 441:589-594.
100. Lu J., Bjorkum A.A., Xu M., et al. Selective activation of the extended ventrolateral preoptic nucleus during rapid eye movement sleep. J Neurosci 2002, 22:4568-4576.
101. Horner R.L. Emerging principles and neural substrates underlying tonic sleep-state-dependent influences on respiratory motor activity. Philos Trans R Soc Lond B Biol Sci 2009, 364:2553-2564.
102. Morris C.J., Aeschbach D., Scheer F.A. Circadian system, sleep and endocrinology. Mol Cell Endocrinol 2012, 349:91-104.
103. McGregor R., Siegel J.M. Illuminating the locus coeruleus: control of posture and arousal. Nat Neurosci 2010, 13:1448-1449.
104. Baldwin C.M., Ervin A.M., Mays M.Z., et al. Sleep disturbances, quality of life, and ethnicity: the Sleep Heart Health Study. J Clin Sleep Med 2010, 6:176-183.
105. Broughton R.J. Sleep disorders: disorders of arousal? Enuresis, somnambulism, and nightmares occur in confusional states of arousal, not in "dreaming sleep". Science 1968, 159:1070-1078.
106. Stickgold R. Sleep: off-line memory reprocessing. Trends Cogn Sci 1998, 2:484-492.
107. Staner L. Sleep-wake mechanisms and drug discovery: sleep EEG as a tool for the development of CNS-acting drugs. Dialogues Clin Neurosci 2002, 4:342-350.
108. Armitage R. The effects of antidepressants on sleep in patients with depression. Can J Psychiatry 2000, 45:803-809.
109. Jia F., Chandra D., Homanics G.E., et al. Ethanol modulates synaptic and extrasynaptic GABAA receptors in the thalamus. J Pharmacol Exp Ther 2008, 326:475-482.
110. Sigel E. Mapping of the benzodiazepine recognition site on GABA(A) receptors. Curr Top Med Chem 2002, 2:833-839.
111. Poceta J.S. Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case series. J Clin Sleep Med 2011, 7:632-638.
112. Kavey N.B., Whyte J., Resor S.R., et al. Somnambulism in adults. Neurology 1990, 40:749-752.
113. Juszczak G.R. Desensitization of GABAergic receptors as a mechanism of zolpidem-induced somnambulism. Med Hypotheses 2011, 77:230-233.
114. Madhusoodanan S., Bogunovic O.J. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf 2004, 3:485-493.
115. Issa F.G., Sullivan C.E. Alcohol, snoring and sleep apnea. J Neurol Neurosurg Psychiatry 1982, 45:353-359.
116. Horner R.L. The tongue and its control by sleep state-dependent modulators. Arch Ital Biol 2011, 149:406-425.
117. Franks N.P. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 2008, 9:370-386.
118. Franks N.P., Zecharia A.Y. Sleep and general anesthesia. Can J Anaesth 2011, 58:139-148.
119. Brown E.N., Lydic R., Schiff N.D. General anesthesia, sleep, and coma. N Engl J Med 2010, 363:2638-2650.
120. Lazarus M., Shen H.Y., Cherasse Y., et al. Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci 2011, 31:10067-10075.
121. Roehrs T., Merlotti L., Halpin D., et al. Effects of theophylline on nocturnal sleep and daytime sleepiness/alertness. Chest 1995, 108:382-387.
122. Volkow N.D., Fowler J.S., Logan J., et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 2009, 301:1148-1154.
123. Ishizuka T., Murotani T., Yamatodani A. Modanifil activates the histaminergic system through the orexinergic neurons. Neurosci Lett 2010, 483:193-196.
124. Huang Q., Zhang L., Tang H., et al. Modafinil modulates GABA-activated currents in rat hippocampal pyramidal neurons. Brain Res 2008, 1208:74-78.
125. Gerrard P., Malcolm R. Mechanisms of modafinil: a review of current research. Neuropsychiatr Dis Treat 2007, 3:349-364.
126. Broughton R.J., Fleming J.A., George C.F., et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997, 49:444-451.
127. Houghton W.C., Scammell T.E., Thorpy M. Pharmacotherapy for cataplexy. Sleep Med Rev 2004, 8:355-366.